Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOCHROMES-P450' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 333 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Anzenbacher, P; Anzenbacherova, E
      Cytochromes P450 and metabolism of xenobiotics

      CELLULAR AND MOLECULAR LIFE SCIENCES
    2. Smith, WA; Freeman, JW; Gupta, RC
      Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l] pyrene in the human breast cells MCF-7

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    3. Saranko, CJ; Meyer, KG; Pluta, LJ; Henderson, RF; Recio, L
      Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    4. Hauford, V; Buchet, JP; Gardinal, S; Ghittori, S; Imbriani, M; Hirvonen, A; Lison, D
      Importance of genetic polymorphisms of drug-metabolizing enzymes for the interpretation of biomarkers of exposure to styrene

      BIOMARKERS
    5. Licata, AC; Dekant, W; Smith, CE; Borghoff, SJ
      A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: Implementing sensitivity and variability analyses

      TOXICOLOGICAL SCIENCES
    6. Zepnik, H; Pahler, A; Schauer, U; Dekant, W
      Ochratoxin A-induced tumor formation: Is there a role of reactive ochratoxin A metabolites?

      TOXICOLOGICAL SCIENCES
    7. Caro, AA; Cederbaum, AL; Stoyanovsky, DA
      Oxidation of the ketoxime acetoxime to nitric oxide by oxygen radical-generating systems

      NITRIC OXIDE-BIOLOGY AND CHEMISTRY
    8. Sieber, V; Martinez, CA; Arnold, FH
      Libraries of hybrid proteins from distantly related sequences

      NATURE BIOTECHNOLOGY
    9. Synold, TW; Dussault, I; Forman, BM
      The orphan nuclear receptor SXR coordinately regulates drug metabolism andefflux

      NATURE MEDICINE
    10. Ekins, S; Wrighton, SA
      Application of in silico approaches to predicting drug-drug interactions

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    11. Wen, Z; Scott, JG
      Cloning of two novel P450 cDNAs from German cockroaches, Blattella germanica (L.): CYP6K1 and CYP6J1

      INSECT MOLECULAR BIOLOGY
    12. Siegle, I; Fritz, P; Eckhardt, K; Zanger, UM; Eichelbaum, M
      Cellular localization and regional distribution of CYP2D6 mRNA and proteinexpression in human brain

      PHARMACOGENETICS
    13. Corchero, J; Pimprale, S; Kimura, S; Gonzalez, FJ
      Organization of the CYP1A cluster on human chromosome 15: implications forgene regulation

      PHARMACOGENETICS
    14. Duetz, WA; van Beilen, JB; Witholt, B
      Using proteins in their natural environment: potential and limitations of microbial whole-cell hydroxylations in applied biocatalysis

      CURRENT OPINION IN BIOTECHNOLOGY
    15. de Groot, FMH; Damen, EWP; Scheeren, HW
      Anticancer prodrugs for application in monotherapy: Targeting hypoxia, tumor-associated enzymes, and receptors

      CURRENT MEDICINAL CHEMISTRY
    16. Washio, T; Arisawa, H; Kohsaka, K; Yasuda, H
      Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    17. Testai, E
      The drug-metabolizing enzymatic system and the experimental tools used forin vitro toxicology for metabolic studies

      CELL BIOLOGY AND TOXICOLOGY
    18. Mihara, K; Matsumura, M; Yoshioka, E; Hanada, K; Nakasa, H; Ohmori, S; Kitada, M; Ogata, H
      Intestinal first-pass metabolism of eperisone in the rat

      PHARMACEUTICAL RESEARCH
    19. Piver, B; Berthou, F; Dreano, Y; Lucas, D
      Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components

      TOXICOLOGY LETTERS
    20. Ishii, M; Xu, BQ; Ding, LR; Fischer, NE; Inaba, T
      Interaction of plasma proteins with cytochromes P450 mediated metabolic reactions: inhibition by human serum albumin and alpha-globulins of the debrisoquine 4-hydroxylation (CYP2D) in liver microsomes of human, hamster and rat

      TOXICOLOGY LETTERS
    21. Bournique, B; Lambert, N; Boukaiba, R; Martinet, M
      In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine 1-carboxamide)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    22. Yoshimura, R; Ueda, N; Nakamura, J
      Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms - Preliminary study

      NEUROPSYCHOBIOLOGY
    23. Walton, K; Dorne, JL; Renwick, AG
      Uncertainty factors for chemical risk assessment: interspecies differencesin the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates

      FOOD AND CHEMICAL TOXICOLOGY
    24. DeVane, CL; Nemeroff, CB
      An evaluation of risperidone drug interactions

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    25. Spina, E; Scordo, MG; Avenoso, A; Perucca, E
      Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    26. Bachrich, T; Thalhammer, T; Jager, W; Haslmayer, P; Alihodzic, B; Bakos, S; Hitchman, E; Senderowicz, AM; Penner, E
      Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases

      HEPATOLOGY
    27. Thatcher, NJ; Murray, S
      Analysis of the glutathione conjugate of paracetamol in human liver microsomal fraction by liquid chromatography mass spectrometry

      BIOMEDICAL CHROMATOGRAPHY
    28. Lewis, DFV
      COMPACT: a structural approach to the modelling of cytochromes P450 and their interactions with xenobiotics

      JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
    29. Stevenson, TH; Gutierrez, AF; Alderton, WK; Lian, LY; Scrutton, NS
      Kinetics of CO binding to the haem domain of murine inducible nitric oxidesynthase: differential effects of haem domain ligands

      BIOCHEMICAL JOURNAL
    30. Ponsoda, X; Pareja, E; Gomez-Lechon, MJ; Fabra, R; Carrasco, E; Trullenque, R; Castell, JV
      Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

      JOURNAL OF HEPATOLOGY
    31. Vigano, L; Locatelli, A; Grasselli, G; Gianni, L
      Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy

      INVESTIGATIONAL NEW DRUGS
    32. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, A
      Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine

      THERAPEUTIC DRUG MONITORING
    33. Le Ferrec, E; Ilyin, G; Maheo, K; Bardiau, C; Courtois, A; Guillouzo, A; Morel, F
      Differential effects of oltipraz on CYP1A and CYP2B in rat lung

      CARCINOGENESIS
    34. Dyck, LE; Davis, BA
      Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine

      DRUG METABOLISM AND DISPOSITION
    35. Lampen, A; Meyer, S; Nau, H
      Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells

      DRUG METABOLISM AND DISPOSITION
    36. Loadman, PM; Swaine, DJ; Bibby, MC; Welham, KJ; Patterson, LH
      A preclinical pharmacokinetic study of the bioreductive drug AQ4N

      DRUG METABOLISM AND DISPOSITION
    37. Hesse, LM; Venkatakrishnan, K; Von Moltke, LL; Shader, RI; Greenblatt, DJ
      CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam

      DRUG METABOLISM AND DISPOSITION
    38. Yasui-Furukori, N; Hidestrand, M; Spina, E; Facciola, G; Scordo, MG; Tybring, G
      Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes

      DRUG METABOLISM AND DISPOSITION
    39. Vickers, AEM; Zollinger, M; Dannecker, R; Tynes, R; Heitz, F; Fischer, V
      In vitro metabolism of tegaserod in human liver and intestine: Assessment of drug interactions

      DRUG METABOLISM AND DISPOSITION
    40. Weaver, RJ
      Assessment of drug-drug interactions concepts and approaches

      XENOBIOTICA
    41. Hoskins, J; Shenfield, G; Murray, M; Gross, A
      Characterization of moclobemide N-oxidation in human liver microsomes

      XENOBIOTICA
    42. Renwick, AB; Lewis, DFV; Fulford, S; Surry, D; Williams, B; Worboys, PD; Cai, X; Wang, RW; Price, RJ; Lake, BG; Evans, DC
      Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4

      XENOBIOTICA
    43. Bai, S; Brunner, LJ; Stepkowski, SM; Napoli, KL; Kahan, BD
      Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat

      TRANSPLANTATION
    44. Kappers, WA; Edwards, RJ; Murray, S; Boobis, AR
      Diazinon is activated by CYP2C19 in human liver

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    45. Bak, S; Feyereisen, R
      The involvement of two P450 enzymes, CYP83B1 and CYP83A1, in auxin homeostasis and glucosinolate biosynthesis

      PLANT PHYSIOLOGY
    46. Pauli-Magnus, C; Rekersbrink, S; Klotz, U; Fromm, MF
      Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    47. Holla, VR; Adas, F; Imig, JD; Zhao, XY; Price, E; Olsen, N; Kovacs, WJ; Magnuson, MA; Keeney, DS; Breyer, MD; Falck, JR; Waterman, MR; Capdevila, JH
      Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    48. Yoshinari, K; Sueyoshi, T; Moore, R; Negishi, M
      Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYP2B1 gene by phenobarbital in rat livers

      MOLECULAR PHARMACOLOGY
    49. Vernia, S; Beaune, P; Coloma, J; Lopez-Garcia, MP
      Differential sensitivity of rat hepatocyte CYP isoforms to self-generated nitric oxide

      FEBS LETTERS
    50. Boek-Dohalska, L; Hodek, P; Sulc, M; Stiborova, M
      alpha-naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6

      CHEMICO-BIOLOGICAL INTERACTIONS
    51. Himmelstein, MW; Carpenter, SC; Hinderliter, PM; Snow, TA; Valentine, R
      The metabolism of beta-chloroprene: preliminary in-vitro studies using liver microsomes

      CHEMICO-BIOLOGICAL INTERACTIONS
    52. Lu, C; Li, AP
      Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog

      CHEMICO-BIOLOGICAL INTERACTIONS
    53. Dupuy, J; Larrieu, G; Braun, J; Alvinerie, M; Galtier, P
      Differential effects of phenobarbital on the constitutive and inducible expression of P4502B and 3A subfamilies in sheep tissues

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    54. Miyata, N; Taniguchi, K; Seki, T; Ishimoto, T; Sato-Watanabe, M; Yasuda, Y; Doi, M; Kametani, S; Tomishima, Y; Ueki, T; Sato, M; Kameo, K
      HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme

      BRITISH JOURNAL OF PHARMACOLOGY
    55. Gonzalez, MC; Marteau, C; Franchi, J; Migliore-Samour, D
      Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation

      BRITISH JOURNAL OF DERMATOLOGY
    56. Schoedel, KA; Sellers, EM; Tyndale, RF
      Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain

      BIOCHEMICAL PHARMACOLOGY
    57. Gilmore, J; Rotondo, F; Pelletier, AM; LaMarre, J; Alaoui-Jamali, M; Kirby, GM
      Identification of a 43-kDa protein in human liver cytosol that binds to the 3 '-untranslated region of CYP2A6 mRNA

      BIOCHEMICAL PHARMACOLOGY
    58. Long, L; Moschel, RC; Dolan, ME
      Debenzylation of O-6-benzyl-8-oxoguanine in human liver: implications for O-6-benzylguanine metabolism

      BIOCHEMICAL PHARMACOLOGY
    59. Murray, BP; Correia, MA
      Ubiquitin-dependent 26S proteasomal pathway: A role in the degradation of native human liver CYP3A4 expressed in Saccharomyces cerevisiae?

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    60. Lobaccaro, JMA; Repa, JJ; Lu, TT; Caira, F; Henry-Berger, J; Volle, DH; Mangelsdorf, DJ
      Regulation of lipid metabolism by the orphan nuclear receptors

      ANNALES D ENDOCRINOLOGIE
    61. Spina, E; Avenoso, A; Facciola, G; Salemi, M; Scordo, MG; Ancione, M; Madia, AG; Perucca, E
      Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

      PSYCHOPHARMACOLOGY
    62. Clemente, MG; De Virgiliis, S
      Autoantigen characterization in liver/kidney microsome positive hepatitis

      DIGESTIVE AND LIVER DISEASE
    63. Amet, Y; Plee-Gautier, E; Berthou, F; Adas, F; French, SW
      Adaptation to chronic ethanol administration emphasized by fatty acid hydroxylations in rat liver and kidney microsomes

      EUROPEAN JOURNAL OF NUTRITION
    64. Vadon-Le Goff, S; Boucher, JL; Mansuy, D
      Oxidation of arylamidoximes by various chemical and biomimetic systems: comparison with their oxidations by hemeproteins

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE
    65. Chiapella, C; Radovan, RD; Moreno, JA; Casares, L; Barbe, J; Llagostera, M
      Plant activation of aromatic amines mediated by cytochromes P450 and flavin-containing monooxygenases

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    66. Celander, MC; Moore, MJ; Stegeman, JJ
      Cellular localization of CYP3A proteins in various tissues from pilot whale (Globicephala melas)

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    67. Williams, TM; Borghoff, SJ
      Induction of testosterone biotransformation enzymes following oral administration of methyl tert-butyl ether to male Sprague-Dawley rats

      TOXICOLOGICAL SCIENCES
    68. Wu, D; Wang, XB; Chen, DF; Niu, TH; Ni, JT; Liu, X; Xu, XP
      Metabolic gene polymorphisms and risk of dysmenorrhea

      EPIDEMIOLOGY
    69. Sarmanova, J; Tynkova, L; Susova, S; Gut, I; Soucek, P
      Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic

      PHARMACOGENETICS
    70. Paulussen, A; Lavrijsen, K; Bohets, H; Hendrickx, J; Verhasselt, P; Luyten, W; Konings, F; Armstrong, M
      Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans

      PHARMACOGENETICS
    71. Nwankwo, JO; Tahnteng, JG; Emerole, GO
      Inhibition of aflatoxin B1 genotoxicity in human liver-derived HepG2 cellsby kolaviron biflavonoids and molecular mechanisms of action

      EUROPEAN JOURNAL OF CANCER PREVENTION
    72. De Rienzo, F; Fanelli, F; Menziani, MC; De Benedetti, PG
      Theoretical investigation of substrate specificity for cytochromes p450 IA2, p450 IID6 and p450 IIIA4

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    73. Ramirez, FC
      Diagnosis and treatment of gastroesophageal reflux disease in the elderly

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    74. Belle, DJ; Ring, BJ; Allerheiligen, SRB; Heathman, MA; O'Brien, LM; Sinha, V; Roskos, LK; Wrighton, SA
      A population approach to enzyme characterization and identification: Application to phenacetin O-deethylation

      PHARMACEUTICAL RESEARCH
    75. Boyle, SP; Craft, JA
      The effect of gender, sexual maturation and xenobiotic treatment on the formation of hydroxymethyl metabolites from 7,12-dimethylbenz[a]anthracene inrat liver microsomes

      TOXICOLOGY LETTERS
    76. Skaare, JU; Bernhoft, A; Derocher, A; Gabrielsen, GW; Goksoyr, A; Henriksen, E; Larsen, HJ; Lie, E; Wiig, O
      Organochlorines in top predators at Svalbard - occurrence, levels and effects

      TOXICOLOGY LETTERS
    77. Michalets, EL; Williams, CR
      Drug interactions with cisapride - Clinical implications

      CLINICAL PHARMACOKINETICS
    78. Caccia, S
      Biotransformation of post-clozapine antipsychotics - Pharmacological implications

      CLINICAL PHARMACOKINETICS
    79. Westphal, JF
      Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    80. Hashemi, E; Till, C; Ioannides, C
      Stability of cytochrome P450 proteins in cultured precision-cut rat liver slices

      TOXICOLOGY
    81. Lewis, DFV
      Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles

      TOXICOLOGY
    82. Wiseman, A; Lewis, DFV; Ridgway, T; Wiseman, H
      Cytochromes P450 enzymes for clean food-processing: limitations of imitations!

      JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
    83. Genter, MB; Burman, DM; Dingeldein, MW; Clough, I; Bolon, B
      Evolution of alachlor-induced nasal neoplasms in the Long-Evans rat

      TOXICOLOGIC PATHOLOGY
    84. Spina, E; Avenoso, A; Facciola, G; Salemi, M; Scordo, MG; Giacobello, T; Madia, AG; Perucca, E
      Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate

      THERAPEUTIC DRUG MONITORING
    85. Tucker, GT
      Advances in understanding drug metabolism and its contribution to variability in patient response

      THERAPEUTIC DRUG MONITORING
    86. Ma, B; Prueksaritanont, T; Lin, JH
      Drug interactions with calcium channel blockers: Possible involvement of metabolite-intermediate complexation with CYP3A

      DRUG METABOLISM AND DISPOSITION
    87. Miksys, S; Rao, Y; Sellers, EM; Kwan, M; Mendis, D; Tyndale, RF
      Regional and cellular distribution of CYP2D subfamily members in rat brain

      XENOBIOTICA
    88. Henderson, MC; Miranda, CL; Stevens, JF; Deinzer, ML; Buhler, DR
      In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus

      XENOBIOTICA
    89. Moran, JH; Mitchell, LA; Bradbury, JA; Qu, W; Zeldin, DC; Schnellmann, RG; Grant, DF
      Analysis of the cytotoxic properties of linoleic acid metabolites producedby renal and hepatic P450s

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    90. Gu, J; Su, T; Chen, Y; Zhang, QY; Ding, XX
      Expression of biotransformation enzymes in human fetal olfactory mucosa: Potential roles in developmental toxicity

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    91. Sinclair, PR; Gorman, N; Walton, HS; Bement, WJ; Dalton, TP; Sinclair, JF; Smith, AG; Nebert, DW
      CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene andiron

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    92. Ahmad, M; Nicholls, PJ; Smith, HJ; Ahmadi, M
      Effect of P450 isozyme-selective inhibitors on in-vitro metabolism of retinoic acid by rat hepatic microsomes

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    93. Katiyar, SK; Matsui, MS; Mukhtar, H
      Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    94. Noguchi, S; Jianmongkol, S; Bender, AT; Kamada, Y; Demady, DR; Osawa, Y
      Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    95. Huel, G; Campagna, D; Girard, F; Moreau, T; Blot, P
      Does selenium reduce the risk of threatened preterm delivery associated with placental cytochrome P450-1A1 activity?

      ENVIRONMENTAL RESEARCH
    96. Skalova, L; Nobilis, M; Szotakova, B; Wsol, V; Kubicek, V; Baliharova, V; Kvasnickova, E
      Effect of substituents on microsomal reduction of benzo(c)fluorene N-oxides

      CHEMICO-BIOLOGICAL INTERACTIONS
    97. Longo, V; Amato, G; Salvetti, A; Gervasi, PG
      Heterogenous effects of anthraquinones on drug-metabolizing enzymes in theliver and small intestine of rat

      CHEMICO-BIOLOGICAL INTERACTIONS
    98. Silva, ID; Gaspar, J; da Costa, GG; Rodrigues, AS; Laires, A; Rueff, J
      Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents

      CHEMICO-BIOLOGICAL INTERACTIONS
    99. Borek-Dohalska, L; Stiborova, M
      Texanes - Anticancer drug with unique mechanism of action

      CHEMICKE LISTY
    100. Zalma, A; von Moltke, LL; Granda, BW; Harmatz, JS; Shader, RI; Greenblatt, DJ
      In vitro metabolism of trazodone by CYP3A: Inhibition by ketoconazole and human immunodeficiency viral protease inhibitors

      BIOLOGICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 21:19:35